Denbury Inc. short interest in 2021
In 2021, Denbury Inc.'s disclosed short interest ran from 1.47% of shares outstanding on 12 Feb 2021 to 6.77% on 31 Dec 2021, a change of +5.30 percentage points. The year's high was 7.95% on 15 Oct 2021 and its low 1.37% on 15 Mar 2021, averaging 5.37% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.48 days on 30 Jul 2021. Full history: Denbury Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 1.47% (12 Feb 2021)
- End of year
- 6.77% (31 Dec 2021)
- Change
- +5.30 pp
- High
- 7.95% (15 Oct 2021)
- Low
- 1.37% (15 Mar 2021)
- Average
- 5.37%
- Highest days to cover
- 7.48 (30 Jul 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Feb 2021 | 1.47% | 1.36 | |
| 26 Feb 2021 | 1.80% | 1.38 | results (8-K) |
| 15 Mar 2021 | 1.37% | 1.00 | 10-K filed |
| 31 Mar 2021 | 2.15% | 1.00 | |
| 15 Apr 2021 | 2.19% | 1.38 | |
| 30 Apr 2021 | 3.06% | 2.57 | |
| 14 May 2021 | 4.56% | 3.00 | 10-Q filed, results (8-K) |
| 28 May 2021 | 7.30% | 3.14 | |
| 15 Jun 2021 | 6.18% | 2.97 | |
| 30 Jun 2021 | 7.28% | 1.74 | |
| 15 Jul 2021 | 6.85% | 5.77 | |
| 30 Jul 2021 | 6.89% | 7.48 | |
| 13 Aug 2021 | 6.85% | 7.06 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 6.99% | 5.90 | |
| 15 Sep 2021 | 7.01% | 5.64 | |
| 30 Sep 2021 | 6.88% | 5.44 | |
| 15 Oct 2021 | 7.95% | 4.58 | |
| 29 Oct 2021 | 7.13% | 4.93 | |
| 15 Nov 2021 | 5.63% | 4.31 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 5.70% | 4.44 | |
| 15 Dec 2021 | 6.18% | 5.50 | |
| 31 Dec 2021 | 6.77% | 7.28 |
See also: Denbury Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.